MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ctr.14595

Медицинская библиотека · Clinical transplantation · 2022

Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol-related liver disease.

Selim Ranya, Zhou Yueren, Rupp Loralee B, Trudeau Sheri, Naffouj Sandra, Shamaa Omar, Ahmed Abdelwahab, Jafri Syed-Mohammed, Gordon Stuart C, Segal Antu, Gonzalez Humberto C

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Serum phosphatidylethanol (PEth) is a highly sensitive test to detect alcohol use. We evaluated whether the availability of PEth testing impacted rates of liver transplant evaluation terminations and delistings.

METHODS

Medical record data were collected for patients who initiated transplant evaluation due to alcohol-related liver disease in the pre-PEth (2017) or PEth (2019) eras. Inverse probability weighting (IPW) was used to balance baseline patient characteristics. Outcomes included termination of evaluation or delisting due to alcohol use; patients were censored at receipt of transplant; death was considered a competing risk. The Fine-Gray method was performed to determine whether PEth testing affected risk of evaluation termination/ delisting due to alcohol use.

RESULTS

Three hundred and seventy-five patients with alcohol-related indications for transplant (157 in 2017; 210 in 2019) were included. The final IPW-adjusted model for the composite outcome of terminations/delisting due to alcohol use retained two significant variables (P < .05): PEth era and BMI category. Patients evaluated during the PEth era were almost three times more likely to experience an alcohol-related termination/delisting than those in the pre-PEth era (sHR = 2.86; 95%CI 1.67-4.97)

CONCLUSION

We found that availability of PEth testing at our institution was associated with a higher rate of exclusion of patients from eligibility for liver transplant. Use of PEth testing has significant potential to inform decisions regarding transplant candidacy for patients with alcohol-related liver disease.

Для цитирования: Selim Ranya, Zhou Yueren, Rupp Loralee B, Trudeau Sheri, Naffouj Sandra, Shamaa Omar, Ahmed Abdelwahab, Jafri Syed-Mohammed, Gordon Stuart C, Segal Antu, Gonzalez Humberto C. Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol-related liver disease.. Clinical transplantation. 2022. DOI: 10.1111/ctr.14595.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.